Sommetrics provides update on the pivotal supra clinical trial for sleep apnea and recent corporate accomplishments

Vista, calif.--(business wire)--sommetrics, a private company developing products and services to improve sleep health, today released an update on its key accomplishments during the first quarter of 2022. chief among these accomplishments was the company's advancing clinical activities aimed at obtaining fda market clearance for its flagship product, aersleep® ii, that is targeted for the treatment of obstructive sleep apnea in those unable to use standard therapy with continuous positive airw
INGN Ratings Summary
INGN Quant Ranking